Your Messages Inbox
Your Article Summary
See Latest ArticlesGilead Sciences Marketing Authorisation Application for Regadenoson Validated by European Medicines Agency
Gilead, 05/29/09
Gilead Sciences, Inc. announced that the company's Marketing Authorisation Application for regadenoson, an investigational pharmacologic stress agent for radionuclide myocardial perfusion imaging, was validated by the European Medicines Agency. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use for formal review to determine whether regadenoson is a safe and efficacious pharmacologic stress agent in humans.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor